Arvinas and Pfizer submit NDA to FDA for vepdegestrant after Phase 3 data shows efficacy in ESR1-mutated ER+/HER2- breast cancer patients read more
ABM Industries Inc. shares are trading higher after the company reported second-quarter fiscal year 2025 earnings. read more
Latest Ratings for PLCE Date Firm Action From To Mar 2022 B. Riley Securities Maintains Buy Mar 2022 Citigroup Maintains Neutral Mar 2022 Telsey Advisory Group Maintains Outperform View More Analyst Ratings for PLCE View the Latest Analyst Ratings read more
Latest Ratings for URBN Date Firm Action From To Mar 2022 Morgan Stanley Maintains Overweight Mar 2022 Barclays Maintains Overweight Mar 2022 JP Morgan Maintains Neutral View More Analyst Ratings for URBN View the Latest Analyst Ratings read more
